Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Dorchester Minerals, L.P. Announces Second Quarter Results
-
Opendoor Announces Second Quarter of 2024 Financial Results
-
INmune Bio Inc. Announces Second Quarter 2024 Results and Provides Business Update
-
Ultragenyx Reports Second Quarter 2024 Financial Results and Corporate Update
-
Arteris Announces Financial Results for the Second Quarter 2024 and Third Quarter and Full Year 2024 Guidance
-
iRhythm Technologies Announces Chief Financial Officer Transition
-
Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
-
LeMaitre Q2 2024 Financial Results
-
Fox Factory Holding Corp. Reports Second Quarter Fiscal 2024 Financial Results
-
El Pollo Loco Holdings, Inc. Announces Second Quarter 2024 Financial Results
-
Great Elm Capital Corp. Announces Second Quarter 2024 Financial Results
-
T2 Biosystems to Attend Upcoming Investor Conferences
-
Lipella Pharmaceuticals Announces Closing of $1.28 Million Registered Direct Offering of Common Stock Priced At-the-Market Under Nasdaq Rules
-
Elutia Announces Full Exercise of Warrants Generating $15.7 Million in Gross Proceeds
-
Cardiff Oncology to Report Second Quarter 2024 Results and Provide Business Update
-
Sportsman’s Warehouse Secures $45 Million Term Loan to Strengthen its Balance Sheet and Enhance Liquidity
-
TOMI Environmental Solutions, Inc. Reports 170% Sequential Growth in Second Quarter Revenue With Break Even EPS
-
Fidus Investment Corporation Announces Second Quarter 2024 Financial Results
-
SPX Technologies Reports Second Quarter 2024 Results
-
DMC Global Reports Second Quarter Financial Results
-
Oncocyte to Announce Second Quarter 2024 Financial Results on August 8
-
Sight Sciences Reports Second Quarter 2024 Financial Results and Narrows Full Year 2024 Financial Guidance
-
Merit Medical to Present 6-Month Outcomes from Randomized Arm of WRAPSODY™ Arteriovenous Access Efficacy (WAVE) Pivotal Study at Two Upcoming Medical Meetings
-
Oncternal Therapeutics to Provide Business Update and Report Second Quarter 2024 Financial Results
-
RCM Technologies, Inc. Announces Conference Call
-
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
AVITA Medical Names Robin VanDenburgh as SVP of U.S. Commercial Sales
-
Western Governors University Awarded CompTIA Academic Partner of the Year
-
Shattuck Labs Reports Second Quarter 2024 Financial Results and Recent Business Highlights
-
Sensus Healthcare Issues Reminder That its Second Quarter 2024 Financial Results and Business Update Conference Call Will be Held on Thursday, August 8, 2024
-
Haynes International, Inc. Reports Third Quarter Fiscal 2024 Financial Results
-
Vigil Neuroscience Highlights Publication on ALSP Genetic Mutation Prevalence in Neurology Genetics
-
NextCure Provides Business Update and Reports Second Quarter 2024 Financial Results
-
SIGA Reports Financial Results for Three and Six Months Ended June 30, 2024
-
ZimVie Reports Second Quarter 2024 Financial Results
-
Lulus Releases Preliminary Second Quarter Results and Announces Second Quarter Earnings Call Date
-
iRhythm Technologies Announces Second Quarter 2024 Financial Results
-
Sun Country Airlines Reports Second Quarter 2024 Results
-
Zymeworks Provides Corporate Update and Reports Second Quarter 2024 Financial Results
-
OPKO Health to Report Second Quarter 2024 Financial Results on August 7, 2024
-
Altair Announces Second Quarter 2024 Financial Results
-
Fidus Investment Corporation Announces Second Quarter 2024 Financial Results
-
Casella Waste Systems, Inc. Expands its Footprint in the Mid-Atlantic with Two Acquisitions
-
Paylocity Announces Fourth Quarter and Full Fiscal Year 2024 Financial Results
-
Oxbridge Re Announces 2024 Second Quarter Results on August 8, 2024
-
Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
-
Myriad Genetics Advances International Reorganization and Completes Sale of EndoPredict Business to Eurobio Scientific
-
Adaptive Biotechnologies Reports Second Quarter 2024 Financial Results
-
Athira Pharma Reports Second Quarter 2024 Financial Results and Pipeline and Business Updates
-
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2024
